Enterprise Value
505.2M
Cash
122.4M
Avg Qtr Burn
-14.19M
Short % of Float
9.83%
Insider Ownership
0.03%
Institutional Own.
-
Qtr Updated
12/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
AV-101 Details Pulmonary arterial hypertension | Phase 2/3 Data readout |